Fluid transfer assembly with venting arrangement

Information

  • Patent Grant
  • 8684994
  • Patent Number
    8,684,994
  • Date Filed
    Wednesday, February 23, 2011
    13 years ago
  • Date Issued
    Tuesday, April 1, 2014
    10 years ago
Abstract
A fluid transfer assembly including a vented female vial adapter and male vial adapter for use with a pair of vials including a vial with contents under negative pressure for liquid drug reconstitution and administration purposes. The vented female vial adapter includes a venting arrangement and the male vial adapter includes a sealing arrangement for selectively sealing the venting arrangement. The fluid transfer assembly is designed such that only filtered air is drawn into the vial under negative pressure subsequent to reconstitution of liquid drug contents to ensure sterile conditions.
Description
CROSS-REFERENCE TO RELATED APPLICATION

This application is a Section 371 of International Application No. PCT/IL2011/000186, filed Feb. 23, 2011, which was published in the English language on Sep. 1, 2011, under International Publication No. WO 2011/104711 A1, and the disclosure of which is incorporated herein by reference.


FIELD OF THE INVENTION

The invention relates to fluid transfer assemblies for liquid drug reconstitution and administration.


BACKGROUND OF THE INVENTION

Commonly owned U.S. Pat. No. 6,558,365 to Zinger et al. illustrates and describes a fluid transfer assembly including a pair of initially inter-engaged vial adapters for use with a pair of vials for liquid drug reconstitution and administration purposes. Such fluid transfer assemblies are commercially available under the registered trademark MIX2VIAL® from the present Applicant Medimop Medical Projects Ltd., Ra'anana, Israel. The pair of vial adapters includes a vial adapter including a female connector referred to hereinafter as a “female vial adapter” and another vial adapter including a male connector referred to hereinafter as a “male vial adapter”. The male and female connectors are Luer connectors and preferably Luer lock connectors. The vials typically include one vial containing diluent and another vial containing a powdered drug medicament under vacuum. Typical vial sizes include 13 mm neck diameter and 20 mm neck diameter.


Liquid drug reconstitution and administration starting from an initial assembled configuration of a fluid transfer assembly includes the steps of:


(a) holding the diluent containing vial on a flat surface and downwardly snap fitting the male vial adapter thereonto;


(b) inverting the fluid transfer assembly to hold the fluid transfer assembly upright with the male vial adapter and its connected diluent containing vial above the female vial adapter;


(c) holding the medicament containing vial on a flat surface and downwardly snap fitting the female vial adapter thereonto whereupon the prevailing vacuum in the medicament containing vial rapidly draws the diluent from the diluent containing vial thereinto to form a reconstituted liquid drug and leaves a residual vacuum in the sealed assemblage of the fluid transfer assembly and two connected vials;


(d) gently agitating the sealed assemblage of the fluid transfer assembly and the two connected vials to fully reconstitute the liquid drug medicament in the vial connected to the female vial adapter;


(e) detaching the male vial adapter from the female vial adapter by unscrewing the male Luer lock connector from the female Luer connector;


(f) screw threading a syringe with a male Luer lock connector onto the female vial adapter;


(g) inverting the female vial adapter and its connected vial for aspirating the reconstituted liquid drug into the syringe; and


(h) unscrewing the syringe from the female vial adapter, attaching a needleand administering the reconstituted liquid drug.


Steps (a) to (d) are performed under sterile conditions but step (e) draws ambient air into the vial connected to the female vial adapter via its female connector to equalize the negative pressure therein. Ambient air particularly in outpatient clinics, hospitals, and the like, may be septic and therefore contaminate reconstituted liquid drug contents. Moreover, in some circumstances, female vial adapters are prepared in advance of immediate use and left standing for subsequent use thereby leaving their reconstituted liquid drug contents exposed to ambient air.


SUMMARY OF THE INVENTION

The present invention is directed toward fluid transfer assemblies similar in construction and operation as the hitherto described fluid transfer assemblies and additionally provisioned for precluding undesirable drawing of potentially septic air into a vial connected to a female vial adapter on detaching a male vial adapter therefrom thereby maintaining the sterility of a reconstituted liquid drug. This is achieved by replacing a hitherto employed non-vented female vial adapter by a vented female vial adapter including a venting arrangement having an air filter and one or more vent ports and providing an otherwise conventional male vial adapter with a sealing arrangement having one or more port sealing members for sealing the vent ports.


The present invention is designed such that the aforesaid step e) detaching the male vial adapter from the female vial adapter is effectively divided into a two step process undiscernable to a user as follows: First, initial axial displacement causes the sealing arrangement to open a female vial adapter's vent ports for drawing ambient air into its connected vial containing a reconstituted liquid drug through its air filter to equalize its residual vacuum with ambient pressure prior to the male connector unsealing the female connector. The air filter precludes septic air being drawn into a reconstituted liquid drug containing vial thereby maintaining the sterility of its contents. And second, continued axial displacement to complete the mechanical detachment of the male vial adapter from the female vial adapter.


The fluid transfer assemblies of the present invention are preferably blister packed with their male vial adapters pre-assembled on their female vial adapters thereby expediting their use for reconstitution and administration purposes. Alternatively, a male vial adapter and a female vial adapter can be supplied as discrete components requiring a user to assembly the male vial adapter on the female vial adapter prior to reconstitution and administration purposes. Fluid transfer assemblies can be pre-assembled in a ready for reconstitution state, namely, their male connectors seal their female connectors and their sealing arrangements seal their venting arrangements. Alternatively, fluid transfer assemblies can be pre-assembled in a non ready for reconstitution state with their sealing arrangements axially displaced from their vent ports and therefore not sealing their venting arrangements. Such fluid transfer assemblies require axial displacement of their male vial adapter toward their female vial adapter for urging their male connectors to seal their female connectors and their sealing arrangements to seal their venting arrangements thereby priming the fluid transfer assemblies from their non ready for reconstitution state to their ready for reconstitution state. Such axial displacement preferable automatically occurs during the snap fit of a fluid transfer assembly on its vials for reconstitution purposes. The latter non ready for reconstitution state is envisaged to afford a longer shelf life than the former ready for reconstitution state by virtue of the sealing arrangement only sealing the venting arrangement as required for reconstitution purposes and thereby precluding inadvertent adhesion therebetween.


The present invention can be readily implemented for use with a wide range of vials including inter alia 13 mm neck diameter vials, 20 mm neck diameter vials and so-called large diameter vials with typically 28 mm, 32 mm and larger neck diameter. The one or more port sealing members are preferably designed to additionally stabilize a male vial adapter on a vented female vial adapter as well as sealing the latter's one or more vent ports. Fluid transfer assemblies intended for use with large diameter large vials preferably include a vented female vial adapter having a female connector adapted to receive an IV spike. Fluid transfer assemblies can include alternative inter-engagement arrangements to a screw threading arrangement including inter alia friction fit arrangements, and the like.


The female vial adapter can be optionally provided with a closure for sealing its female connector for maintaining a sterile environment for its reconstituted liquid drug contents subsequent to mechanical detachment of the male vial adapter from the female vial adapter. The closure can be in the form of a manually placed cap, a pre-split septum, and the like.





BRIEF DESCRIPTION OF DRAWINGS

In order to understand the invention and to see how it can be carried out in practice, preferred embodiments will now be described, by way of non-limiting examples only, with reference to the accompanying drawings in which similar parts are likewise numbered, and in which:



FIG. 1 is a pictorial representation of a fluid transfer assembly in an initial ready for reconstitution state in accordance with a first embodiment of the present invention, a syringe and pair of vials, the fluid transfer assembly including a vented female vial adapter and a male vial adapter;



FIG. 2 is a top perspective cutaway view of FIG. 1's vented female vial adapter along line A-A in FIG. 1;



FIG. 3 is a bottom perspective cutaway view of FIG. 1's vented female vial adapter;



FIG. 4 is a longitudinal cross section of FIG. 1's male vial adapter;



FIG. 5 is a bottom perspective cutaway view of FIG. 1's vented female vial adapter;



FIG. 6 is a front perspective view of an assemblage of FIG. 1's fluid transfer assembly and two connected vials for reconstitution of liquid drug contents;



FIG. 7 is a longitudinal cross section of a FIG. 6's assemblage along line B-B therein;



FIG. 8 is a longitudinal cross section of a FIG. 6's assemblage along line B-B therein subsequent to initial axial displacement of the male vial adapter from the vented female vial adapter;



FIG. 9 is a front perspective view of FIG. 6's assemblage subsequent to complete mechanical detachment of the male vial adapter from the vented female vial adapter;



FIG. 10 is a pictorial representation of a fluid transfer assembly in an initial ready for reconstitution state in accordance with a second embodiment of the present invention;



FIG. 11 is a pictorial representation of FIG. 10's vented female vial adapter and male vial adapter;



FIG. 12 is a pictorial representation of a fluid transfer assembly in an initial ready for reconstitution state in accordance with a third embodiment of the present invention;



FIG. 13 is a pictorial representation of FIG. 12's vented female vial adapter and male vial adapter;



FIG. 14 is a pictorial representation of a fluid transfer assembly in accordance with a fourth embodiment of the present invention for use with large diameter vials and an IV spike;



FIG. 15 is a longitudinal cross section of FIG. 14's vented female vial connector along line C-C therein;



FIG. 16 is a longitudinal cross section of FIG. 14's vented female vial connector with an IV spike for liquid drug administration;



FIG. 17 is a pictorial representation of FIG. 1's vented female vial adapter including a manually placed cap for sealing its female connector;



FIG. 18 is a top perspective cutaway view of FIG. 1's vented female vial adapter along line A-A in FIG. 1 including a pre-split septum for sealing its female connector;



FIG. 19 is a pictorial representation of a fluid transfer assembly in an initial non ready for reconstitution state, the fluid transfer assembly including a vented female vial adapter and a male vial adapter;



FIG. 20 is a pictorial representation of FIG. 19's male vial adapter; and



FIG. 21 is a pictorial representation of FIG. 19's fluid transfer assembly in a ready for reconstitution state.





DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS OF THE INVENTION


FIG. 1 shows a fluid transfer assembly 100 in an initial ready for reconstitution state for use with an empty syringe 10 and a pair of vials 20A and 20B constituting medicinal vessels. The fluid transfer assembly 100 has a longitudinal axis 101 and includes a vented female vial adapter 110 having a venting arrangement 110A and initially screw threaded on a male vial adapter 130 having a sealing arrangement 130A for selectively sealing the venting, arrangement 110A. The syringe 10 includes a barrel 11 with a plunger 12 and a male Luer lock connector 13. The syringe 10 can be formed with other types of male connectors. The vials 20 include an open topped bottle 21 sealed by a vial stopper 22 capped by a metal band 23. The vial 20A has a vial interior 24 containing either a powder or liquid medicament 26 under negative pressure. The vial 20B has a vial interior 24 containing a liquid medicament 27 for reconstituting the vial contents 26 to form reconstituted liquid drug contents 28. The liquid medicament 27 can be diluent or containing an active drug component.



FIGS. 2 and 3 show the vented female vial adapter 110 includes a transverse top wall 111, a downward depending skirt 112 with flexing members 113 for snap fitting onto the vial 20A, and a downward depending pointed cannula 114 having a liquid transfer lumen 116 for puncturing the vial 20A's vial stopper 22, and an oppositely directed female connector 117 in flow communication with the liquid transfer lumen 116. The female connector 117 is preferably a female Luer connector including an external screw thread 117A at its free end.


The venting arrangement 110A includes an annular air filter 118 disposed beneath the top wall 111, four equi-spaced circular vent ports 119 formed in the top wall 111 and a venting lumen 121 formed in the pointed cannula 114 for establishing flow communication between the vent ports 119 and the vial 20A's vial interior on snap fitting the female vial adapter 110 on the vial 20A. The vent ports 119 are flush with the top wall 111 and each include a vent aperture 122 and an annular elastomer rim 123 disposed on the top wall 111 for sealing same on application of an axial force thereon.



FIGS. 4 and 5 show the male vial adapter 130 includes a transverse top wall 131, a downward depending skirt 132 with flexing members 133 for snap fitting onto the vial 20B, a downward depending pointed cannula 134 with a liquid transfer lumen 136 for puncturing the vial 20B's vial stopper 22 and an oppositely directed male connector 137 in flow communication with the liquid transfer lumen 136. The male, connector 137 is preferably a male Luer lock connector for screw threading engagement with the female Luer connector 117.


The sealing arrangement 130A includes a pair of opposite axial directed port sealing members 138 for supporting an annular port sealing member 139 for applying an axial force on the elastomer rims 123 for sealing the vent ports 119 in the initial ready for reconstitution state of the fluid transfer assembly 100. The sealing arrangement 130A also stabilizes the male vial adapter 130 on the vented female vial adapter 110 in the fluid transfer assembly 100's initial ready for reconstitution state.



FIGS. 6 to 9 show use of the fluid transfer assembly 100 for reconstitution and administration purposes.



FIGS. 6 and 7 show an assemblage 140 of the fluid transfer assembly 100 snap fitted on the two vials 20A and 20B on following the aforesaid steps (a) to (d) to form reconstituted liquid drug contents 28 in the vial 20A. The assemblage 140 includes the female connector 117 in sealed engagement with the male connector 137 and the sealing arrangement 130A sealing the vent ports 119 prior to snap fitting the fluid transfer assembly 100 on the vials 20A and 20B. The axial separation between the opposite top walls 111 and 131 is denoted by the height H1. The arrow P denotes drawing of the liquid medicament 27 from the vial 20B into the vial 20A to form the reconstituted liquid drug contents 28.



FIG. 8 shows an initial axial displacement of the male vial adapter 130 from the vented female vial adapter 110 by initial unscrewing the male Luer lock connector 137 from the female Luer connector 117 denoted by arrow Q. The initial axial displacement is denoted by the axial separation H2 where H2 is slightly greater than H1 and is designed to enable the sealing arrangement 130A to open the vent ports 119 before the male Luer lock connector 137 unseals the female Luer connector 117. The initial axial displacement is typically in the order of the pitch of the Luer lock inter-engagement between the male Luer lock connector 137 and the female lock connector 117. The opening of the venting arrangement 110A draws filtered air through the air filter 118 into the vial 20A as denoted by arrows R to equalize its residual negative pressure with ambient pressure.



FIG. 9 shows continued axial displacement of the male vial adapter 130 from the vented female vial adapter 110 by continuing unscrewing the male Luer lock connector 137 from the female Luer connector 117 until complete mechanical detachment thereby exposing the female Luer connector 117 for attachment of the syringe 10 for administration of reconstituted liquid drug contents 27.



FIGS. 10 and 11 show a fluid transfer assembly 150 similar in construction and operation as the fluid transfer assembly 100 and therefore similar parts are likewise numbered. The former 150 includes a vented female vial adapter 110 with a venting arrangement 151 modified with respect to the venting arrangement 110A. The venting arrangement 151 includes open topped vent ports 119 raised with respect to the top wall 111 and each having a vent aperture 122 inclined towards the longitudinal axis 101. The vent ports 119 are provided with annular elastomer rims 123 for sealing same on depression by an annular port sealing member 139 in an initial ready for reconstitution state of the fluid transfer assembly 150.



FIGS. 12 and 13 show a fluid transfer assembly 160 similar in construction and operation as the fluid transfer assembly 100 and therefore similar parts are likewise numbered. The former 160 includes a vented female vial adapter 110 with a venting arrangement 161 modified with respect to the venting arrangement 110A. The venting arrangement 161 includes quarter sphere shaped vent ports 119 raised with respect to the top wall 111 and each having a vent aperture 122 facing radial outward with respect to the longitudinal axis 101 and fitted with a semi-circular elastomer rim 123. The male vial adapter 130 has three elongated port sealing members 139 for sealing the vent ports 119 in an initial ready for reconstitution state of the fluid transfer assembly 160.



FIG. 14 shows a fluid transfer assembly 170 for use with a pair of large diameter vials, for example 32 mm neck diameter, and an IV device 30 including an IV spike 31, a chamber 32, and IV tubing 33. The fluid transfer assembly 170 has a similar construction to the fluid transfer assembly 100 and therefore similar parts are likewise numbered. The fluid transfer assembly 170 includes a vented female vial adapter 171 including a venting arrangement 110A and a male vial adapter 172 including a sealing arrangement 130A. The fluid transfer assembly 170 has an initial ready for reconstitution state with the male vial adapter 172 screw thread engaged on the female vial adapter 171.


The vented female vial adapter 171 differs from the vented female vial adapter 110 insofar its female connector 117 is fashioned for receiving the IV spike 31. The female vial adapter 171 includes a female connector 117 which is taller with respect to its top wall 111 than the female vial adapter 110's female connector 117 to sealingly accommodate the IV spike 31. The male vial adapter 172 includes a port sealing member 139 which is taller with respect to its top wall 131 than the male vial adapter 130's port sealing member 139 to compensate for the female vial adapter 171's female connector 117. FIGS. 15 and 16 show the female connector 117 includes an annular seal 173 for sealing a male connector 137 in an initial ready for reconstitution state of the fluid transfer assembly 170 and an IV spike 31 during liquid drug administration.



FIG. 17 shows FIG. 1's vented female vial adapter 110 including a manually placed cap 124 for sealing its female connector 117 subsequent to reconstitution of liquid drug contents for maintaining sterile conditions while the female vial adapter 110 is left standing for subsequent use. Alternatively, FIG. 18 shows FIG. 1's vented female vial adapter 110 with a pre-split septum 126 for the same purpose.



FIG. 19 shows a fluid transfer assembly 180 similar in construction to the fluid transfer assembly 100 but differing therefrom insofar it has an initial non ready for reconstitution state as opposed to an initial ready for reconstitution state. The fluid transfer assembly 180 includes a female vial adapter 181 having a venting arrangement 110A and a female connector 117 and a male vial adapter 182 having a sealing arrangement 130A and a male connector 137. The female vial adapter 181 can be constituted by either a female vial adapter 110 for use with syringes 10 for administration purposes or a female vial adapter 171 for use with IV devices 30 for administration purposes. The male vial adapter 182 correspondingly includes a suitably shaped and dimensioned male connector 137. The difference between the non ready for reconstitution state and the ready for reconstitution state is that in the former state the male vial adapter 182 is axially displaced from the female vial adapter 181 such that the male connector 137 does not seal the female connector 117 and the sealing arrangement 130A does not seal the venting arrangement 110A.



FIG. 20 shows the male vial adapter 182 is similar to the male vial adapter 130 but differs therefrom in two respects as follows: The sealing arrangement 130A additionally includes a pair of opposite inward directed engagement members 183 for engaging a female connector 117 in the initial non ready for reconstitution state for assembling the male vial adapter 182 on the female vial adapter 181. Also, the male vial adapter 182 includes three equispaced axial directed grip members 184 lateral to the male connector 137 and having inward directed projections 186 for engaging the female connector's external screw thread 117A on axial displacement of the male vial adapter towards the female vial adapter.



FIG. 21 shows the fluid transfer assembly 180 pursuant to snap fitting the male vial adapter 182 on a vial 20B containing a liquid medicament 27. A user applies a downward force F on the female vial adapter 181 causing the female vial adapter 181 to axially move towards the male vial adapter 182. The axial displacement causes the sealing arrangement 130A to seal the vent ports 119A and the male connector 137 to seal the female connector 117 thereby effectively priming the fluid transfer assembly 180 into its ready for reconstitution state. The inward directed projections 186 engage the external screw thread 117A in a similar manner to a male Luer lock connector such that a user unscrews the male vial adapter 182 from the female vial adapter 181 for the initial opening of the venting arrangement 110A to enable drawing in of filtered air and the subsequent complete mechanical detachment of the male vial adapter 182 from the female vial adapter 181.


While the invention has been described with respect to a limited number of embodiments, it will be appreciated that many variations, modifications, and other applications of the invention can be made within the scope of the appended claims.

Claims
  • 1. A fluid transfer assembly for use with a first vial and a second vial for liquid drug reconstitution and administration purposes, the first vial having a vial opening and a vial stopper sealing the vial opening and a vial interior containing a liquid medicament, the second vial having a vial opening and a vial stopper sealing the vial opening and a vial interior containing a medicament under negative pressure, the liquid medicament intended to reconstitute the second vial's medicament to form reconstituted liquid drug contents, the fluid transfer assembly having a longitudinal axis and comprising: (a) a female vial adapter having a top wall, a skirt with flex members for snap fitting onto the second vial, a pointed cannula for puncturing the second vial's vial stopper on snap fitting said female vial adapter on the second vial, said pointed cannula including a liquid transfer lumen for establishing flow communication with the second vial's vial interior, and a female connector in flow communication with said liquid transfer lumen; and(b) a male vial adapter having a top wall, a skirt with flex members for snap fitting onto the first vial, a pointed cannula for puncturing the first vial's vial stopper on snap fitting said male vial adapter on the first vial, said pointed cannula including a liquid transfer lumen for establishing flow communication with the first vial's vial interior, and a male connector in flow communication with said liquid transfer lumen and for sealing said female connector on assembling said male vial adapter on said female vial adapter for reconstitution of the liquid drug contents, wherein said female vial adapter having a venting arrangement including i) an air filter underlying said top wall, ii) at least one vent port formed in said top wall and iii) a venting lumen formed in said pointed cannula for establishing flow communication between said at least one vent port and the second vial's vial interior on snap fitting said female vial adapter on the second vial, andsaid male vial adapter having a sealing arrangement for sealing said at least one vent port during reconstitution of the liquid drug contents,the arrangement being such that pursuant to initial snap fitting of i) said male vial adapter on the first vial and thereafter ii) said female vial adapter on the second vial, the second vial's negative pressure draws the first vial's liquid medicament thereinto for reconstitution with its medicament for reconstituting the reconstituted liquid drug contents,subsequent axial displacement of said male vial adapter from said female vial adapter initially axially displaces said sealing arrangement from said at least one vent port to open said venting arrangement while said male connector continuously seals said female connector such that the second vial draws filtered air only thereinto to equalize its negative pressure and thereafter completes mechanical detachment of said male vial adapter from said female vial adapter for enabling administration of the reconstituted liquid drug contents.
  • 2. The assembly according to claim 1, wherein said sealing arrangement includes at least one axial directed port sealing member for sealing said at least one vent port during reconstitution of the liquid drug contents.
  • 3. The assembly according to claim 2, wherein said at least one axial directed port sealing member includes an annular port sealing member for simultaneously sealing at least one vent port of said at least one vent port during reconstitution of the liquid drug contents.
  • 4. The assembly according to claim 1, wherein said fluid transfer assembly is pre-assembled in an initial ready for reconstitution state including said male vial adapter assembled on said female vial adapter, said male connector sealing said female connector and said sealing arrangement sealing said at least one vent port.
  • 5. The assembly according to claim 1, wherein said fluid transfer assembly is pre-assembled in an initial non ready for reconstitution state including said male vial adapter assembled on said female vial adapter and said sealing arrangement axially displaced from said at least one vent port thereby not sealing said venting arrangement, said fluid transfer assembly requiring axial displacement of said male vial adapter towards said female vial adapter for urging said male connector to seal said female connector and said sealing arrangement to seal said at least one vent port thereby priming said fluid transfer assembly from said initial non ready for reconstitution state to a ready for reconstitution state.
  • 6. The assembly according to claim 5, wherein said sealing arrangement includes at least one inward directed engagement member for engaging said female connector in said initial non ready for reconstitution state for assembling said male vial adapter on said female vial adapter.
  • 7. The assembly according to claim 5, wherein said male vial adapter includes at least two axial directed grip members lateral to said male connector and having inward directed projections for engaging said female connector's free end on said axial displacement of said male vial adapter towards said female vial adapter.
  • 8. The assembly according to claim 1, wherein said female connector includes an internal annular seal for sealing engagement with said male connector during reconstitution of liquid drug contents and an IV spike during liquid drug administration.
  • 9. The assembly according to claim 1, wherein said female connector includes a manually placed cap for sealing said female connector subsequent to said complete mechanical detachment of said male vial adapter from said female vial adapter.
  • 10. The assembly according to claim 1, wherein said venting arrangement includes at least one hooded vent port having a vent aperture facing radial outward with respect to said longitudinal axis.
Priority Claims (1)
Number Date Country Kind
204141 Feb 2010 IL national
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/IL2011/000186 2/23/2011 WO 00 7/16/2012
Publishing Document Publishing Date Country Kind
WO2011/104711 9/1/2011 WO A
US Referenced Citations (577)
Number Name Date Kind
62333 Holl Feb 1867 A
1021681 Jennings Mar 1912 A
1704817 Ayers Mar 1929 A
1930944 Schmitz, Jr. Oct 1933 A
2326490 Perelson Aug 1943 A
2931668 Baley Apr 1960 A
2968497 Treleman Jan 1961 A
3059643 Barton Oct 1962 A
D198499 Harautuneian Jun 1964 S
3484849 Huebner et al. Dec 1969 A
3618637 Santomieri Nov 1971 A
3757981 Harris, Sr. et al. Sep 1973 A
3788524 Davis et al. Jan 1974 A
3822700 Pennington Jul 1974 A
3826261 Killinger Jul 1974 A
3885607 Peltier May 1975 A
3938520 Scislowicz et al. Feb 1976 A
3957052 Topham May 1976 A
3977555 Larson Aug 1976 A
3993063 Larrabee Nov 1976 A
4020839 Klapp May 1977 A
4051852 Villari Oct 1977 A
4109670 Slagel Aug 1978 A
4121585 Becker, Jr. Oct 1978 A
4161178 Genese Jul 1979 A
4187848 Taylor Feb 1980 A
4203067 Fitzky et al. May 1980 A
4203443 Genese May 1980 A
4210173 Choksi et al. Jul 1980 A
D257286 Folkman Oct 1980 S
4253501 Ogle Mar 1981 A
4296786 Brignola Oct 1981 A
4303067 Connolly et al. Dec 1981 A
4312349 Cohen Jan 1982 A
4314586 Folkman Feb 1982 A
4328802 Curley et al. May 1982 A
4335717 Bujan et al. Jun 1982 A
D267199 Koenig Dec 1982 S
4376634 Prior et al. Mar 1983 A
D268871 Benham et al. May 1983 S
4392850 Elias et al. Jul 1983 A
4410321 Pearson et al. Oct 1983 A
4411662 Pearson Oct 1983 A
D271421 Fetterman Nov 1983 S
4434823 Hudspith Mar 1984 A
4465471 Harris et al. Aug 1984 A
4475915 Sloane Oct 1984 A
4493348 Lemmons Jan 1985 A
4505709 Froning et al. Mar 1985 A
4507113 Dunlap Mar 1985 A
D280018 Scott Aug 1985 S
4532969 Kwaan Aug 1985 A
4564054 Gustavsson Jan 1986 A
4573993 Hoag et al. Mar 1986 A
4576211 Valentini et al. Mar 1986 A
4581014 Millerd et al. Apr 1986 A
4588396 Stroebel et al. May 1986 A
4588403 Weiss et al. May 1986 A
D284603 Loignon Jul 1986 S
4604093 Brown et al. Aug 1986 A
4607671 Aalto et al. Aug 1986 A
4614437 Buehler Sep 1986 A
4638975 Iuchi et al. Jan 1987 A
4639019 Mittleman Jan 1987 A
4667927 Oscarsson May 1987 A
4676530 Nordgren et al. Jun 1987 A
4683975 Booth et al. Aug 1987 A
4697622 Swift et al. Oct 1987 A
4721133 Sundblom Jan 1988 A
4729401 Raines Mar 1988 A
4735608 Sardam Apr 1988 A
4743229 Chu May 1988 A
4743243 Vaillancourt May 1988 A
4752292 Lopez et al. Jun 1988 A
4758235 Tu Jul 1988 A
4759756 Forman et al. Jul 1988 A
4778447 Velde et al. Oct 1988 A
4787898 Raines Nov 1988 A
4797898 Martinez Jan 1989 A
4804366 Zdeb et al. Feb 1989 A
4832690 Kuu May 1989 A
4834152 Howson et al. May 1989 A
4857062 Russell Aug 1989 A
4865592 Rycroft Sep 1989 A
4909290 Coccia Mar 1990 A
4931040 Haber et al. Jun 1990 A
4932944 Jagger et al. Jun 1990 A
4967797 Manska Nov 1990 A
D314050 Sone Jan 1991 S
D314622 Andersson et al. Feb 1991 S
4997430 Van der Heiden et al. Mar 1991 A
5006114 Rogers et al. Apr 1991 A
5035686 Crittenden et al. Jul 1991 A
5041105 D'Alo et al. Aug 1991 A
5045066 Scheuble et al. Sep 1991 A
5049129 Zdeb et al. Sep 1991 A
5053015 Gross Oct 1991 A
5061248 Sacco Oct 1991 A
5088996 Kopfer et al. Feb 1992 A
5096575 Cosack Mar 1992 A
5104387 Pokorney et al. Apr 1992 A
5113904 Aslanian May 1992 A
5122124 Novacek et al. Jun 1992 A
5125908 Cohen Jun 1992 A
5125915 Berry et al. Jun 1992 A
D328788 Sagae et al. Aug 1992 S
5171230 Eland et al. Dec 1992 A
5201705 Berglund et al. Apr 1993 A
5201717 Wyatt et al. Apr 1993 A
5203771 Melker et al. Apr 1993 A
5203775 Frank et al. Apr 1993 A
5211638 Dudar et al. May 1993 A
5232029 Knox et al. Aug 1993 A
5232109 Tirrell et al. Aug 1993 A
5242432 DeFrank Sep 1993 A
5247972 Tetreault Sep 1993 A
D341420 Conn Nov 1993 S
5269768 Cheung Dec 1993 A
5270219 DeCastro et al. Dec 1993 A
5279576 Loo et al. Jan 1994 A
5288290 Brody Feb 1994 A
5300034 Behnke et al. Apr 1994 A
5304163 Bonnici et al. Apr 1994 A
5308483 Sklar et al. May 1994 A
5312377 Dalton May 1994 A
5328474 Raines Jul 1994 A
D349648 Tirrell et al. Aug 1994 S
5334163 Sinnett Aug 1994 A
5334179 Poli et al. Aug 1994 A
5342346 Honda et al. Aug 1994 A
5344417 Wadsworth, Jr. Sep 1994 A
5350372 Ikeda et al. Sep 1994 A
5364386 Fukuoka et al. Nov 1994 A
5364387 Sweeney Nov 1994 A
5374264 Wadsworth, Jr. Dec 1994 A
5385547 Wong et al. Jan 1995 A
5397303 Sancoff et al. Mar 1995 A
5429614 Fowles et al. Jul 1995 A
5433330 Yatsko et al. Jul 1995 A
5445630 Richmond Aug 1995 A
5445631 Uchida Aug 1995 A
5451374 Molina Sep 1995 A
5454805 Brony Oct 1995 A
5464111 Vacek et al. Nov 1995 A
5464123 Scarrow Nov 1995 A
5466219 Lynn et al. Nov 1995 A
5466220 Brenneman Nov 1995 A
5470327 Helgren et al. Nov 1995 A
5478337 Okamoto et al. Dec 1995 A
5492147 Challender et al. Feb 1996 A
D369406 Niedospial et al. Apr 1996 S
5505714 Dassa et al. Apr 1996 A
5509433 Paradis Apr 1996 A
5520659 Hedges May 1996 A
5526853 McPhee et al. Jun 1996 A
5527306 Haining Jun 1996 A
5531695 Swisher Jul 1996 A
5547471 Thompson et al. Aug 1996 A
5549577 Siegel et al. Aug 1996 A
5554128 Hedges Sep 1996 A
5566729 Grabenkort et al. Oct 1996 A
5569191 Meyer Oct 1996 A
5573281 Keller Nov 1996 A
5578015 Robb Nov 1996 A
5583052 Portnoff et al. Dec 1996 A
5584819 Kopfer Dec 1996 A
5591143 Trombley, III et al. Jan 1997 A
5603706 Wyatt et al. Feb 1997 A
5607439 Yoon Mar 1997 A
5611576 Guala Mar 1997 A
5616203 Stevens Apr 1997 A
5636660 Pfleiderer et al. Jun 1997 A
5641010 Maier Jun 1997 A
5645538 Richmond Jul 1997 A
5647845 Haber et al. Jul 1997 A
5651776 Appling et al. Jul 1997 A
5653686 Coulter et al. Aug 1997 A
5674195 Truthan Oct 1997 A
5676346 Leinsing Oct 1997 A
5685845 Grimard Nov 1997 A
5699821 Paradis Dec 1997 A
5702019 Grimard Dec 1997 A
5718346 Weiler Feb 1998 A
D393722 Fangrow, Jr. et al. Apr 1998 S
5738144 Rogers Apr 1998 A
5743312 Pfeifer et al. Apr 1998 A
5746733 Capaccio et al. May 1998 A
5755696 Caizza May 1998 A
5766211 Wood et al. Jun 1998 A
5772630 Ljungquist Jun 1998 A
5772652 Zielinski Jun 1998 A
RE35841 Frank et al. Jul 1998 E
5776116 Lopez et al. Jul 1998 A
5782872 Muller Jul 1998 A
5806831 Paradis Sep 1998 A
5817082 Niedospial, Jr. et al. Oct 1998 A
5820621 Yale et al. Oct 1998 A
5827262 Neftel et al. Oct 1998 A
5832971 Yale et al. Nov 1998 A
5833213 Ryan Nov 1998 A
5834744 Risman Nov 1998 A
5839715 Leinsing Nov 1998 A
5853406 Masuda et al. Dec 1998 A
5871110 Grimard et al. Feb 1999 A
5873872 Thibault et al. Feb 1999 A
5879337 Kuracina et al. Mar 1999 A
5879345 Aneas Mar 1999 A
5887633 Yale et al. Mar 1999 A
5890610 Jansen et al. Apr 1999 A
5891129 Daubert et al. Apr 1999 A
5893397 Peterson et al. Apr 1999 A
5897526 Vaillancourt Apr 1999 A
5899468 Apps et al. May 1999 A
5902280 Powles et al. May 1999 A
5902298 Niedospial, Jr. et al. May 1999 A
5911710 Barry et al. Jun 1999 A
5919182 Avallone Jul 1999 A
5921419 Niedospial, Jr. et al. Jul 1999 A
5924584 Hellstrom et al. Jul 1999 A
5925029 Jansen et al. Jul 1999 A
5935112 Stevens et al. Aug 1999 A
5941848 Nishimoto et al. Aug 1999 A
5944700 Nguyen et al. Aug 1999 A
5954104 Daubert et al. Sep 1999 A
5971181 Niedospial, Jr. et al. Oct 1999 A
5971965 Mayer Oct 1999 A
5989237 Fowles et al. Nov 1999 A
6003566 Thibault et al. Dec 1999 A
6004278 Botich et al. Dec 1999 A
6019750 Fowles et al. Feb 2000 A
6022339 Fowles et al. Feb 2000 A
6036171 Weinheimer et al. Mar 2000 A
6039093 Mrotzek et al. Mar 2000 A
6039302 Cote, Sr. et al. Mar 2000 A
D422357 Niedospial, Jr. et al. Apr 2000 S
6063068 Fowles et al. May 2000 A
D427308 Zinger Jun 2000 S
6070623 Aneas Jun 2000 A
6071270 Fowles et al. Jun 2000 A
6080132 Cole et al. Jun 2000 A
6089541 Weinheimer et al. Jul 2000 A
6090091 Fowles et al. Jul 2000 A
6090093 Thibault et al. Jul 2000 A
6099511 Devos et al. Aug 2000 A
6113068 Ryan Sep 2000 A
6113583 Fowles et al. Sep 2000 A
6117114 Paradis Sep 2000 A
6139534 Niedospial, Jr. et al. Oct 2000 A
6142446 Leinsing Nov 2000 A
6146362 Turnbull et al. Nov 2000 A
6156025 Niedospial, Jr. et al. Dec 2000 A
6159192 Fowles et al. Dec 2000 A
6168037 Grimard Jan 2001 B1
6171287 Lynn et al. Jan 2001 B1
6171293 Rowley et al. Jan 2001 B1
6173852 Browne Jan 2001 B1
6174304 Weston Jan 2001 B1
6179822 Niedospial, Jr. Jan 2001 B1
6179823 Niedospial, Jr. Jan 2001 B1
6206861 Mayer Mar 2001 B1
6221041 Russo Apr 2001 B1
6221054 Martin et al. Apr 2001 B1
6221065 Davis Apr 2001 B1
6238372 Zinger et al. May 2001 B1
6245044 Daw et al. Jun 2001 B1
D445501 Niedospial, Jr. Jul 2001 S
D445895 Svendsen Jul 2001 S
6253804 Safabash Jul 2001 B1
6258078 Thilly Jul 2001 B1
6280430 Neftel et al. Aug 2001 B1
6290688 Lopez et al. Sep 2001 B1
6296621 Masuda et al. Oct 2001 B1
6299131 Ryan Oct 2001 B1
6343629 Wessman et al. Feb 2002 B1
6348044 Coletti et al. Feb 2002 B1
6358236 DeFoggi et al. Mar 2002 B1
6364866 Furr et al. Apr 2002 B1
6378576 Thibault et al. Apr 2002 B2
6378714 Jansen et al. Apr 2002 B1
6379340 Zinger et al. Apr 2002 B1
6382442 Thibault et al. May 2002 B1
6408897 Laurent et al. Jun 2002 B1
6409708 Wessman Jun 2002 B1
6440107 Trombley, III et al. Aug 2002 B1
6453949 Chau Sep 2002 B1
6453956 Safabash Sep 2002 B2
6474375 Spero et al. Nov 2002 B2
6478788 Aneas Nov 2002 B1
D468015 Horppu Dec 2002 S
6499617 Niedospial, Jr. et al. Dec 2002 B1
6503240 Niedospial, Jr. et al. Jan 2003 B1
6503244 Hayman Jan 2003 B2
6520932 Taylor Feb 2003 B2
6524278 Campbell et al. Feb 2003 B1
6524295 Daubert et al. Feb 2003 B2
D472316 Douglas et al. Mar 2003 S
6530903 Wang et al. Mar 2003 B2
6537263 Aneas Mar 2003 B1
D472630 Douglas et al. Apr 2003 S
6544246 Niedospial, Jr. Apr 2003 B1
6551299 Miyoshi et al. Apr 2003 B2
6558365 Zinger et al. May 2003 B2
6571837 Jansen et al. Jun 2003 B2
6572591 Mayer Jun 2003 B2
6575955 Azzolini Jun 2003 B2
6581593 Rubin et al. Jun 2003 B1
6582415 Fowles et al. Jun 2003 B1
6591876 Safabash Jul 2003 B2
6601721 Jansen et al. Aug 2003 B2
6626309 Jansen et al. Sep 2003 B1
D482121 Harding et al. Nov 2003 S
D482447 Harding et al. Nov 2003 S
6651956 Miller Nov 2003 B2
6652509 Helgren et al. Nov 2003 B1
D483487 Harding et al. Dec 2003 S
D483869 Tran et al. Dec 2003 S
6656433 Sasso Dec 2003 B2
6666852 Niedospial, Jr. Dec 2003 B2
6681810 Weston Jan 2004 B2
6681946 Jansen et al. Jan 2004 B1
6682509 Lopez Jan 2004 B2
6692478 Paradis Feb 2004 B1
6692829 Stubler et al. Feb 2004 B2
6695829 Hellstrom et al. Feb 2004 B2
6699229 Zinger et al. Mar 2004 B2
6706022 Leinsing et al. Mar 2004 B1
6706031 Manera Mar 2004 B2
6715520 Andreasson et al. Apr 2004 B2
6729370 Norton et al. May 2004 B2
6736798 Ohkubo et al. May 2004 B2
6745998 Doyle Jun 2004 B2
6746438 Arnissolle Jun 2004 B1
6752180 Delay Jun 2004 B2
D495416 Dimeo et al. Aug 2004 S
D496457 Prais et al. Sep 2004 S
6802490 Leinsing et al. Oct 2004 B2
6832994 Niedospial, Jr. et al. Dec 2004 B2
6852103 Fowles et al. Feb 2005 B2
6875203 Fowles et al. Apr 2005 B1
6875205 Leinsing Apr 2005 B2
6878131 Novacek et al. Apr 2005 B2
6890328 Fowles et al. May 2005 B2
6901975 Aramata et al. Jun 2005 B2
6945417 Jansen et al. Sep 2005 B2
6948522 Newbrough et al. Sep 2005 B2
6949086 Ferguson et al. Sep 2005 B2
6957745 Thibault et al. Oct 2005 B2
RE38996 Crawford et al. Feb 2006 E
6994315 Ryan et al. Feb 2006 B2
6997916 Simas, Jr. et al. Feb 2006 B2
6997917 Niedospial, Jr. et al. Feb 2006 B2
7024968 Raudabough et al. Apr 2006 B2
7070589 Lolachi et al. Jul 2006 B2
7074216 Fowles et al. Jul 2006 B2
7083600 Meloul Aug 2006 B2
7086431 D'Antonio et al. Aug 2006 B2
7100890 Cote, Sr. et al. Sep 2006 B2
7150735 Hickle Dec 2006 B2
7192423 Wong Mar 2007 B2
7195623 Burroughs et al. Mar 2007 B2
7241285 Dikeman Jul 2007 B1
7294122 Kubo et al. Nov 2007 B2
7306199 Leinsing et al. Dec 2007 B2
D561348 Zinger et al. Feb 2008 S
7326188 Russell et al. Feb 2008 B1
7326194 Zinger et al. Feb 2008 B2
7350764 Raybuck Apr 2008 B2
7354422 Riesenberger et al. Apr 2008 B2
7354427 Fangrow Apr 2008 B2
7425209 Fowles et al. Sep 2008 B2
7435246 Zihlmann Oct 2008 B2
7452348 Hasegawa Nov 2008 B2
7470257 Norton et al. Dec 2008 B2
7470265 Brugger et al. Dec 2008 B2
7472932 Weber et al. Jan 2009 B2
7488297 Flaherty Feb 2009 B2
7491197 Jansen et al. Feb 2009 B2
7497848 Leinsing et al. Mar 2009 B2
7523967 Steppe Apr 2009 B2
7530546 Ryan et al. May 2009 B2
D595420 Suzuki et al. Jun 2009 S
D595421 Suzuki et al. Jun 2009 S
7540863 Haindl Jun 2009 B2
7540865 Griffin et al. Jun 2009 B2
7544191 Peluso et al. Jun 2009 B2
D595862 Suzuki et al. Jul 2009 S
D595863 Suzuki et al. Jul 2009 S
7611487 Woehr et al. Nov 2009 B2
7611502 Daly Nov 2009 B2
7615041 Sullivan et al. Nov 2009 B2
7628779 Aneas Dec 2009 B2
7632261 Zinger et al. Dec 2009 B2
D608900 Giraud et al. Jan 2010 S
7654995 Warren et al. Feb 2010 B2
7695445 Yuki Apr 2010 B2
D616090 Kawamura May 2010 S
7713247 Lopez May 2010 B2
7717886 Lopez May 2010 B2
7722090 Burton et al. May 2010 B2
D616984 Gilboa Jun 2010 S
7731678 Tennican et al. Jun 2010 B2
7743799 Mosler et al. Jun 2010 B2
7758082 Weigel et al. Jul 2010 B2
7762524 Cawthon et al. Jul 2010 B2
7766304 Phillips Aug 2010 B2
7771383 Truitt et al. Aug 2010 B2
7799009 Niedospial, Jr. et al. Sep 2010 B2
7803140 Fangrow, Jr. Sep 2010 B2
D627216 Fulginiti Nov 2010 S
D630732 Lev et al. Jan 2011 S
7862537 Zinger et al. Jan 2011 B2
7867215 Akerlund et al. Jan 2011 B2
7879018 Zinger et al. Feb 2011 B2
D634007 Zinger et al. Mar 2011 S
7900659 Whitley et al. Mar 2011 B2
D637713 Nord et al. May 2011 S
D644104 Maeda et al. Aug 2011 S
7993328 Whitley Aug 2011 B2
8016809 Zinger et al. Sep 2011 B2
8025653 Capitaine et al. Sep 2011 B2
8029472 Leinsing et al. Oct 2011 B2
8038123 Ruschke et al. Oct 2011 B2
8066688 Zinger et al. Nov 2011 B2
8070739 Zinger et al. Dec 2011 B2
8096525 Ryan Jan 2012 B2
8105314 Fangrow, Jr. Jan 2012 B2
D655017 Mosler et al. Feb 2012 S
8122923 Kraus et al. Feb 2012 B2
D655071 Davila Mar 2012 S
8157784 Rogers Apr 2012 B2
8167863 Yow May 2012 B2
8172824 Pfeifer et al. May 2012 B2
8177768 Leinsing May 2012 B2
8182452 Mansour et al. May 2012 B2
8197459 Jansen et al. Jun 2012 B2
8211069 Fangrow, Jr. Jul 2012 B2
8225959 Lambrecht Jul 2012 B2
8241268 Whitley Aug 2012 B2
8262628 Fangrow, Jr. Sep 2012 B2
D669980 Lev et al. Oct 2012 S
8287513 Ellstrom et al. Oct 2012 B2
D674088 Lev et al. Jan 2013 S
8480646 Nord et al. Jul 2013 B2
8506548 Okiyama Aug 2013 B2
8523837 Wiggins et al. Sep 2013 B2
8545476 Ariagno et al. Oct 2013 B2
8551067 Zinger et al. Oct 2013 B2
8556879 Okiyama Oct 2013 B2
20010000347 Hellstrom et al. Apr 2001 A1
20010025671 Safabash Oct 2001 A1
20010029360 Miyoshi et al. Oct 2001 A1
20010051793 Weston Dec 2001 A1
20020017328 Loo Feb 2002 A1
20020066715 Niedospial Jun 2002 A1
20020087118 Reynolds et al. Jul 2002 A1
20020087141 Zinger et al. Jul 2002 A1
20020087144 Zinger et al. Jul 2002 A1
20020121496 Thiebault et al. Sep 2002 A1
20020123736 Fowles et al. Sep 2002 A1
20020127150 Sasso Sep 2002 A1
20020128628 Fathallah Sep 2002 A1
20020173752 Polzin Nov 2002 A1
20020193777 Aneas Dec 2002 A1
20030028156 Juliar Feb 2003 A1
20030036725 Lavi et al. Feb 2003 A1
20030068354 Reif et al. Apr 2003 A1
20030073971 Saker Apr 2003 A1
20030100866 Reynolds May 2003 A1
20030120209 Jensen et al. Jun 2003 A1
20030153895 Leinsing Aug 2003 A1
20030187420 Akerlund et al. Oct 2003 A1
20030191445 Wallen et al. Oct 2003 A1
20030195479 Kuracina et al. Oct 2003 A1
20030199846 Fowles et al. Oct 2003 A1
20030199847 Akerlund et al. Oct 2003 A1
20040024354 Reynolds Feb 2004 A1
20040044327 Hasegawa Mar 2004 A1
20040073189 Wyatt et al. Apr 2004 A1
20040153047 Blank et al. Aug 2004 A1
20040181192 Cuppy Sep 2004 A1
20040204699 Hanly et al. Oct 2004 A1
20040217315 Doyle Nov 2004 A1
20040236305 Jansen et al. Nov 2004 A1
20050015070 Delnevo et al. Jan 2005 A1
20050055008 Paradis et al. Mar 2005 A1
20050124964 Niedospial et al. Jun 2005 A1
20050137566 Fowles et al. Jun 2005 A1
20050148994 Leinsing Jul 2005 A1
20050159724 Enerson Jul 2005 A1
20050182383 Wallen Aug 2005 A1
20050261637 Miller Nov 2005 A1
20060030832 Niedospial et al. Feb 2006 A1
20060079834 Tennican et al. Apr 2006 A1
20060089594 Landau Apr 2006 A1
20060089603 Truitt et al. Apr 2006 A1
20060095015 Hobbs et al. May 2006 A1
20060106360 Wong May 2006 A1
20060135948 Varma Jun 2006 A1
20060253084 Nordgren Nov 2006 A1
20070024995 Hayashi Feb 2007 A1
20070060904 Vedrine et al. Mar 2007 A1
20070079894 Kraus et al. Apr 2007 A1
20070083164 Barrelle et al. Apr 2007 A1
20070088252 Pestotnik et al. Apr 2007 A1
20070088293 Fangrow Apr 2007 A1
20070088313 Zinger et al. Apr 2007 A1
20070106244 Mosler et al. May 2007 A1
20070112324 Hamedi-Sangsari May 2007 A1
20070156112 Walsh Jul 2007 A1
20070167904 Zinger et al. Jul 2007 A1
20070191760 Iguchi et al. Aug 2007 A1
20070191764 Zihlmann Aug 2007 A1
20070191767 Hennessy et al. Aug 2007 A1
20070219483 Kitani et al. Sep 2007 A1
20070244461 Fangrow Oct 2007 A1
20070244462 Fangrow Oct 2007 A1
20070244463 Warren et al. Oct 2007 A1
20070249995 Van Manen Oct 2007 A1
20070255202 Kitani et al. Nov 2007 A1
20070265574 Tennican et al. Nov 2007 A1
20070265581 Funamura et al. Nov 2007 A1
20070270778 Zinger et al. Nov 2007 A9
20070287953 Ziv et al. Dec 2007 A1
20070299404 Katoh et al. Dec 2007 A1
20080009789 Zinger et al. Jan 2008 A1
20080009822 Enerson Jan 2008 A1
20080172024 Yow Jul 2008 A1
20080249479 Zinger et al. Oct 2008 A1
20080249498 Fangrow Oct 2008 A1
20080287905 Hiejima et al. Nov 2008 A1
20080294100 de Costa et al. Nov 2008 A1
20080306439 Nelson et al. Dec 2008 A1
20080312634 Helmerson et al. Dec 2008 A1
20090012492 Zihlmann Jan 2009 A1
20090082750 Denenburg et al. Mar 2009 A1
20090143758 Okiyama Jun 2009 A1
20090177177 Zinger et al. Jul 2009 A1
20090177178 Pedersen Jul 2009 A1
20090187140 Racz Jul 2009 A1
20090216212 Fangrow, Jr. Aug 2009 A1
20090267011 Hatton et al. Oct 2009 A1
20090299325 Vedrine et al. Dec 2009 A1
20090326506 Hasegawa et al. Dec 2009 A1
20100010443 Morgan et al. Jan 2010 A1
20100022985 Sullivan et al. Jan 2010 A1
20100030181 Helle et al. Feb 2010 A1
20100036319 Drake et al. Feb 2010 A1
20100076397 Reed et al. Mar 2010 A1
20100087786 Zinger et al. Apr 2010 A1
20100137827 Warren et al. Jun 2010 A1
20100168712 Tuckwell et al. Jul 2010 A1
20100179506 Shemesh et al. Jul 2010 A1
20100204670 Kraushaar et al. Aug 2010 A1
20100241088 Ranalletta et al. Sep 2010 A1
20100274184 Chun Oct 2010 A1
20100286661 Raday et al. Nov 2010 A1
20100312220 Kalitzki Dec 2010 A1
20110054440 Lewis Mar 2011 A1
20110224640 Kuhn et al. Sep 2011 A1
20110230856 Kyle et al. Sep 2011 A1
20110264069 Bochenko Oct 2011 A1
20110276007 Denenburg Nov 2011 A1
20110319827 Leinsing et al. Dec 2011 A1
20120022469 Alpert Jan 2012 A1
20120053555 Ariagno et al. Mar 2012 A1
20120059346 Sheppard et al. Mar 2012 A1
20120078214 Finke et al. Mar 2012 A1
20120123382 Kubo May 2012 A1
20120184938 Lev et al. Jul 2012 A1
20120215182 Mansour et al. Aug 2012 A1
20120220977 Yow Aug 2012 A1
20120220978 Lev et al. Aug 2012 A1
20120265163 Cheng et al. Oct 2012 A1
20120310203 Khaled et al. Dec 2012 A1
20130053814 Mueller-Beckhaus et al. Feb 2013 A1
20130096493 Kubo et al. Apr 2013 A1
20130199669 Moy et al. Aug 2013 A1
Foreign Referenced Citations (106)
Number Date Country
1913926 Sep 1970 DE
4122476 Jan 1993 DE
19504413 Aug 1996 DE
202004012714 Nov 2004 DE
202009011019 Dec 2010 DE
0192661 Sep 1986 EP
0195018 Sep 1986 EP
0258913 Mar 1988 EP
0416454 Mar 1991 EP
0518397 Dec 1992 EP
0521460 Jan 1993 EP
0637443 Feb 1995 EP
0737467 Oct 1996 EP
761562 Mar 1997 EP
765652 Apr 1997 EP
765853 Apr 1997 EP
0806597 Nov 1997 EP
0814866 Jan 1998 EP
829248 Mar 1998 EP
0856331 Aug 1998 EP
882441 Dec 1998 EP
897708 Feb 1999 EP
0898951 Mar 1999 EP
960616 Dec 1999 EP
1008337 Jun 2000 EP
1029526 Aug 2000 EP
1034809 Sep 2000 EP
1051988 Nov 2000 EP
1323403 Jul 2003 EP
1329210 Jul 2003 EP
1396250 Mar 2004 EP
1454609 Sep 2004 EP
1454650 Sep 2004 EP
1498097 Jan 2005 EP
1872824 Jan 2008 EP
1919432 May 2008 EP
1930038 Jun 2008 EP
2351548 Aug 2011 EP
2351549 Aug 2011 EP
2029242 Oct 1970 FR
2856660 Dec 2004 FR
2869795 Nov 2005 FR
2931363 Nov 2009 FR
1444210 Jul 1976 GB
171662 Oct 2005 IL
03-062426 Sep 1991 JP
4329954 Nov 1992 JP
06-050656 Jul 1994 JP
H08-000710 Jan 1996 JP
09-104460 Apr 1997 JP
09-104461 Apr 1997 JP
10-118158 May 1998 JP
H10-504736 May 1998 JP
11503627 Mar 1999 JP
11-319031 Nov 1999 JP
2000-508934 Jul 2000 JP
2000-237278 Sep 2000 JP
2001-505083 Apr 2001 JP
2002-035140 Feb 2002 JP
2002-516160 Jun 2002 JP
2002-355318 Dec 2002 JP
2003-033441 Feb 2003 JP
2003-102807 Apr 2003 JP
2004-097253 Apr 2004 JP
2004-522541 Jul 2004 JP
9403373 Feb 1994 WO
9507066 Mar 1995 WO
9600053 Jan 1996 WO
9629113 Sep 1996 WO
9736636 Oct 1997 WO
9832411 Jul 1998 WO
9837854 Sep 1998 WO
9961093 Dec 1999 WO
0128490 Apr 2001 WO
0130425 May 2001 WO
0132524 May 2001 WO
0160311 Aug 2001 WO
0191693 Dec 2001 WO
0209797 Feb 2002 WO
0236191 May 2002 WO
02089900 Nov 2002 WO
03051423 Jun 2003 WO
03079956 Oct 2003 WO
2004041148 May 2004 WO
2005002492 Jan 2005 WO
2005041846 May 2005 WO
2005105014 Nov 2005 WO
2006099441 Sep 2006 WO
2007015233 Feb 2007 WO
2007017868 Feb 2007 WO
2007052252 May 2007 WO
2007105221 Sep 2007 WO
2009026443 Feb 2009 WO
2009029010 Mar 2009 WO
2009038860 Mar 2009 WO
2009038860 Mar 2009 WO
2009040804 Apr 2009 WO
2009087572 Jul 2009 WO
2009093249 Jul 2009 WO
2009112489 Sep 2009 WO
2009146088 Dec 2009 WO
2011058545 May 2011 WO
2011058548 May 2011 WO
2011077434 Jun 2011 WO
2011104711 Sep 2011 WO
2012143921 Oct 2012 WO
Non-Patent Literature Citations (100)
Entry
Grifols Vial Adapter Product Literature, 2 pages, Jan. 2002.
Novel Transfer, Mixing and Drug Delivery Systems, MOP Medimop Medical Projects Ltd. Catalog, 4 pages, Rev. 4, 2004.
Smart Site.RTM. Alaris Medical Systems Product Brochure, 4 pages, Issue 1, Oct. 1999.
Smart Site.RTM. Needle-Free Systems, Alaris Medical Systems Webpage, 4 pages, Feb. 2006.
Photographs of Alaris Medical Systems SmartSite.RTM. device, 5 pages, 2002.
Non-Vented Vial Access Pin with ULTRASITE.RTM. Valve, B. Braun Medical, Inc. website and product description, 3 pages, Feb. 2006.
Office Action Issued Oct. 6, 2003 in U.S. Appl. No. 10/062,796.
Office Action Issued Feb. 22, 2005 in U.S. Appl. No. 10/062,796.
Office Action Issued Oct. 5, 2005 in U.S. Appl. No. 10/062,796.
Office Action Issued Feb. 20, 2009 in U.S. Appl. No. 11/694,297.
Int'l Search Report Issued Dec. 6, 2006 in Int'l Application No. PCT/IL2006/000912.
Int'l Preliminary Report on Patentability Issued Dec. 4, 2007 in Int'l Application No. PCT/IL2006/000912.
Int'l Search Report Issued Jul. 27, 2007 in Int'l Application No. PCT/IL2007/000343.
Int'l Preliminary Report on Patentability Issued Jun. 19, 2008 in Int'l Application No. PCT/IL2007/000343.
Int'l Search Report Issued Mar. 27, 2009 in Int'l Application No. PCT/US2008/070024.
Int'l Search Report Issued Oct. 17, 2005 in Int'l Application No. PCT/IL2005/000376.
Int'l Preliminary Report on Patentability Issued Jun. 19, 2006 in Int'l Application No. PCT/IL2005/000376.
Int'l Search Report Issued Aug. 25, 2008 in Int'l Application No. PCT/IL2008/000517.
Written Opinion of the ISR Issued Oct. 17, 2009 in Int'l Application No. PCT/IL08/00517.
Int'l Preliminary Report on Patenability Issued Oct. 20, 2009 in Int'l Application No. PCT/IL2008/000517.
Written Opinion of the Int'l Searching Authority Issued Oct. 27, 2008 in Int'l Application No. PCT/US2008/070024.
Int'l Search Report Issued Mar. 12, 2009 in Int'l Application No. PCT/IL2008/001278.
Office Action Issued Jan. 20, 2010 in JP Application No. 2007-510229.
Office Action Issued Apr. 20, 2010 in U.S. Appl. No. 11/997,569.
Int'l Search Report dated Nov. 20, 2006 in Int'l Application No. PCT/IL2006/000881.
Office Action Issued May 27, 2010 in U.S. Appl. No. 11/559,152.
Decision to Grant mailed Apr. 12, 2010 in EP Application No. 08738307.1.
Office Action issued Jun. 1, 2010 in U.S. Appl. No. 11/568,421.
Office Action issued Nov. 12, 2010 in U.S. Appl. No. 29/334,697.
The MixJect transfer system, as shown in the article, “Advanced Delivery Devices,” Drug Delivery Technology Jul./Aug. 2007 vol. 7 No. 7 [on-line]. [Retrieved from Internet May 14, 2010.] URL: <http://www.drugdeiverytech-online.com/drugdelivery/200707/?pg=28pg28>. (3 pages).
Publication date of Israeli Patent Application 186290 [on-line]. [Retrieved from Internet May 24, 2010]. URL:<http://www.ilpatsearch.justrice.gov.il/UI/RequestsList.aspx>. (1 page).
Int'l Search Report issued Nov. 25, 2010 in Int'l Application No. PCT/IL2010/000530.
Office Action issued Feb. 7, 2011 in U.S. Appl. No. 12/783,194.
Office Action issued Dec. 20, 2010 in U.S. Appl. No. 12/063,176.
Office Action issued Dec. 13, 2010 in U.S. Appl. No. 12/293,122.
Office Action issued Nov. 29, 2010 in U.S. Appl. No. 11/568,421.
Office Action issued Dec. 23, 2010 in U.S. Appl. No. 29/334,696.
Int'l Search Report issued on Mar. 17, 2011 in Int'l Application No. PCT/IL2010/000854.
http://www.knovel.com/web/portal/browse/display?—EXT—KNOVEL—DISPLAY—bookid=1023&VerticalID=0 [retrieved on Feb. 9, 2011].
Int'l Search Report issued on Mar. 17, 2011 in Int'l Application No. PCT/IL2010/00915.
Office Action Issued May 12, 2011 in U.S. Appl. No. 12/063,176.
Office Action issued Jul. 11, 2011 in U.S. Appl. No. 12/293,122.
Int'l Search Report issued Jul. 12, 2011 in Int'l Application No. PCT/IL2011/000187.
Int'l Search Report issued Jul. 12, 2011 in Int'l Application No. PCT/IL2011/000186.
Office Action issued Aug. 3, 2011 in JP Application No. 2008-525719.
Int'l Search Report issued Oct. 7, 2011 in Int'l Application No. PCT/IL2011/000511.
Int'l Search Report issued Mar. 6, 2012 in Int'l Application No. PCT/IL2011/000834; Written Opinion.
Int'l Search Report issued Jan. 22, 2013 in Int'l Application No. PCT/IL2012/000354.
Int'l Search Report issued Mar. 18, 2013 in Int'l Application No. PCT/IL2012/050516.
Office Action issued Apr. 2, 2013 in U.S. Appl. No. 13/505,790.
Int'l Search Report and Written Opinion issued Mar. 6, 2012 in Int'l Application No. PCT/IL2011/000834.
U.S. Appl. No. 13/883,289 by Lev, filed May 3, 2013.
Int'l Search Report issued Jun. 5, 2013 in Int'l Application No. PCT/IL2012/050407.
Int'l Search Report issued Jun. 19, 2013 in Int'l Application No. PCT/IL201/050167.
Int'l Search Report issued Jul. 1, 2013 in Int'l Application No. PCT/IL2013/050180.
Int'l Search Report issued Jul. 31, 2103 in Int'l Application No. PCT/IL2013/050313.
Int'l Search Report issued Jul. 26, 2013 in Int'l Application No. PCT/IL2013/050316.
English translation of an Office Action issued Jun. 19, 2013 in JP Application No. 2012-531551.
Office Action issued Aug. 20, 2013 in U.S. Appl. No. 13/576,461 by Lev.
Int'l Preliminary Report on Patentability issued Aug. 28, 2012 in Int'l Application No. PCT/IL2011/000186.
Office Action issued Mar. 1, 2012 in JP Application No. 2007-510229.
Int'l Search Report issued Mar. 7, 2012 in Int'l Application No. PCT/IL2011/000829; Written Opinion.
Office Action issued Mar. 13, 2012 in CA Application No. 2,563,643.
Office Action issued Mar. 1, 2012 in CN Application No. 2008801108283.4.
Office Action issued Mar. 6, 2012 in U.S. Appl. No. 12/678,928.
Int'l Search Report issued Feb. 3, 2011 in Int'l Application No. PCT/IL2010/000777; Written Opinion.
Int'l Search Report issued Mar. 17, 2011 in Int'l Application No. PCT/IL2010/000854; Written Opinion.
Int'l Search Report issued Mar. 17, 2011 in Int'l Application No. PCT/IL2010/000915; Written Opinion.
U.S. Appl. No. 13/505,790 by Lev, filed May 3, 2012.
U.S. Appl. No. 13/505,881 by Lev, filed May 3, 2012.
U.S. Appl. No. 13/576,461 by Lev, filed Aug. 1, 2012.
Office Action issued Jun. 14, 2012 in U.S. Appl. No. 29/376,980.
Office Action issued Jun. 15, 2012 in U.S. Appl. No. 29/413,170.
Office Action issued Jun. 21, 2012 in U.S. Appl. No. 12/596,167.
Int'l Search Report issued Aug. 16, 2012 in Int'l Application No. PCT/IL2012/000164.
International Search Report Issued Jan. 23, 2007 in Int'l Application No. PCT/IL/2006/001228.
IV disposables sets catalogue, Cardinal Health, Alaris® products, SmartSite® access devices and accessories product No. 10013365, SmartSite add-on bag access device with spike adapter and needle-free valve bag access port, pp. 1-5, Fall edition (2007).
Drug Adminsitration Systems product information sheets; http://www.westpharma.com/eu/en/products/Pages/Vial2Bag.aspx; pp. 1-3 (admitted prior art).
Office Action Issued Jun. 8, 2010 in U.S. Appl. No. 12/112,490 by Zinger.
Office Action issued Sep. 28, 2010 in U.S. Appl. No. 12/112,490 by Zinger.
Article with picture of West Pharmaceutical Services' Vial2Bag Needleless System, [on-line]; ISIPS Newsletter, Oct. 26, 2007]; retrieved from Internet Feb. 16, 2010]; URL:<http://www.isips.org/reports/ISIPS—Newsletter—October—26—2007. html.> (7 pages. see pp. 5-6).
Office Action issued Jun. 15, 2011 in JP Application No. 2008-538492.
Translation of Office Action issued Jun. 18, 2012 in JP Application No. 2008-538492.
Translation of Office Action issued Apr. 15, 2013 in JP Application No. 2008-538492.
Office Action issued Jul. 13, 2012 in U.S. Appl. No. 12/112,490 by Zinger.
Office Action issued Jan. 23, 2013 in U.S. Appl. No. 12/112,490 by Zinger.
Int'l Preliminary Report on Patentability issued May 6, 2008 in Int'l Application No. PCT/IL2006/001228.
Int'l Search Report & Written Opinion issued on Mar. 7, 2012 in Int'l Application No. PCT/IL2011/000829.
U.S. Appl. No. 13/884,981 by Denenburg, filed May 13, 2013.
Office Action issued May 31, 2013 in U.S. Appl. No. 13/505,790.
Int'l Search Report issued Jun. 19, 2013 in Int'l Application No. PCT/IL2013/050167.
U.S. Appl. No. 14/005,751 by Denenburg, filed Sep. 17, 2013.
English translation of an Office Action issued Jul. 26, 2013 in JP Application No. 2012-538464.
U.S. Appl. No. 29/438,134 by Lev, filed Nov. 27, 2012.
U.S. Appl. No. 29/438,141 by Gilboa, filed Nov. 27, 2012.
English translation of an Office Action issued Sep. 10, 2013 in JP Application No. 2012-554468.
Office Action issued Nov. 11, 2013 in IL Application No. 218730.
U.S. Appl. No. 29/478,723 by Lev, filed Jan. 8, 2014.
U.S. Appl. No. 29/478,726 by Lev, filed Jan. 8, 2014.
Office Action issued Jan. 2, 2014 in U.S. Appl. No. 13/505,881 by Lev.
Related Publications (1)
Number Date Country
20120323210 A1 Dec 2012 US